NCT03947827View on ClinicalTrials.gov

Minocycline As Adjunctive Treatment for Treatment Resistant Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

January 7, 2025

Study Completion Date

January 7, 2025

Conditions
Treatment Resistant Depression
Interventions
DRUG

Minocycline

Participants will be randomized to receive either Minocycline or placebo added to standard oral antidepressants.

Trial Locations (1)

M6J 1H4

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

Centre for Addiction and Mental Health

OTHER

NCT03947827 - Minocycline As Adjunctive Treatment for Treatment Resistant Depression | Biotech Hunter | Biotech Hunter